Magnetic Resonance Imaging Scanners and Accessories Industry Data Book Covers Magnetic Resonance Imaging, MRI Coils & Motion Tracking Systems Market.
Global magnetic resonance imaging scanners and accessories industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. Access the Global Magnetic Resonance Imaging Scanners and Accessories Industry Data Book, 2023 to 2030, Compiled Report By Grand View Research Magnetic Resonance Imaging Market Report Highlights The global magnetic resonance imaging (MRI) market size was valued at USD 5.26 billion in 2022 and is anticipated to grow at a CAGR of 7.1% over the forecast period. • The adoption of advanced imaging technologies is augmenting the growth of the global market • The open system segment is anticipated to be the fastest-growing segment during the forecast period due to its efficiency in accommodating all sizes of patients without feeling claustrophobic • MRI for neurological and brain disorders dominated the market due to the growing number of neurological conditions and increasing demand for less invasive diagnostic procedures • The high-field MRI segment is expected to experience the fastest growth rate due to its efficiency in providing detailed images for diagnosis • Imaging centers are expected to exhibit the highest growth rate during the forecast period. Government initiatives to improve primary care are one of the major factors impacting the segment growth • In 2023, North America dominated the global market with the largest revenue share owing to continuous research and adoption of advanced techniques in the region • Asia Pacific is anticipated to grow at the fastest growth rate from 2024 to 2030 due to the growing number of clinical studies in the region for high-field MRI machines MRI Coils Market Report Highlights The global magnetic resonance imaging coils market size was valued at USD 7.99 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.9% from 2023 to 2030.
Motion Tracking Systems Market Report Highlights The global MRI motion tracking systems market size was valued at USD 2.76 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 20.8% from 2023 to 2030.
Order your copy of the Free Sample of “Magnetic Resonance Imaging Scanners and Accessories Industry Data Book - Magnetic Resonance Imaging, MRI Coils & Motion Tracking Systems Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Magnetic Resonance Imaging Scanners and Accessories Industry Data Book Competitive Landscape The high price is one of the most impeding factors for the sales of these systems. The major players are focusing on minimizing the prices for medium-strength MRI systems using various methods. Technological advancements in manufacturing and the high influx of these systems in the market is expected to bring the prices down in the upcoming years. Key players operating in the Magnetic Resonance Imaging Scanners and Accessories Industry are – • GE Healthcare • Siemens Healthineers • Toshiba Corporation • Aurora Imaging Technologies, Inc. • Koninklijke Philips N.V. • Esaote SPA • Sanrad Medical Systems Pvt ltd • Fujifilm • MR Instruments, Inc. • RAPID MR International, LLC • ScanMed • Canon Medical Systems Corporation • Hologic Inc. • Bruker • TracInnovations • Kineticor • Metria Innovations
0 Comments
Neurodegenerative Disease Therapeutics Industry Data Book Covers Parkinson’s Disease Treatment and Alzheimer's Therapeutics Market. The global neurodegenerative disease industry combine to account for USD 8.33 billion revenue in 2021, which is expected to reach USD 28.15 billion by 2030, growing at a cumulative rate of 15.6% over the forecast period.
Global neurodegenerative disease therapeutics industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.The following data points will be included in the final product offering in two reports and one sector report overview. Access the Global Neurodegenerative Disease Therapeutics Industry Data Book, 2023 to 2030, Compiled Report By Grand View Research Parkinson’s Disease Treatment Market Insights The global Parkinson’s disease treatment market size was valued at USD 4.28 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.1% from 2022 to 2030. Parkinson’s Disease Treatment Market Report Highlights • By drug class, the Carbidopa-Levodopa segment held the largest revenue share in 2021 due to the high prevalence of PD and easy drug availability for the disease treatment • The retail pharmacy distribution channel segment dominated the global industry in 2021 • This is due to the easy availability of PD drugs in well-established retail pharmacy chains including Walgreens and Walmart • Asia Pacific is expected to be the fastest-growing region during the forecast period due to the entry of new products into the market • In June 2020, Ono Pharmaceutical Co., Ltd. received manufacturing and marketing approval for Ongentys to treat patients with PD in Japan Alzheimer's Therapeutics Market Report Highlights • By product, the cholinesterase inhibitors segment held the largest revenue share in 2022 as it is the current standard of care. In March 2022, the U.S. FDA approved the cholinesterase inhibitor Adlarity (donepezil hydrochloride) developed by Corium Inc. for the treatment of patients with AD • Pipeline drugs are anticipated to witness the fastest growth over the forecast period due to the presence of a strong product pipeline and their expected launch during the forecast period. Biogen’s product lecanemab (BAN2401), an anti-amyloid beta protofibril antibody for treating AD, is currently in phase 3 clinical trials • The hospital pharmacy end-user segment dominated the market in 2022 owing to the high hospitalization rate. According to Alzheimer’s Association report 2022, approximately 32% of total Medicare beneficiaries with Alzheimer’s have at least one hospital discharge annually Order your copy of the Free Sample of “Neurodegenerative Disease Therapeutics Industry Data Book - Parkinson’s Disease Treatment and Alzheimer's Therapeutics Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Neurodegenerative Disease Therapeutics Industry Data Book Competitive Landscape Competitive rivalry in this market is likely to be high due to increasing number of mergers, acquisitions, and partnerships undertaken by major players globally. Many established and clinical-stage pharmaceutical companies are involved in the development of novel therapies & drugs to target people with unmet clinical needs. Key players operating in the Neurodegenerative Disease Therapeutics industry are – • Eisai Co., Ltd. • AbbVie Inc. (Allergan Plc.) • Merck & Co., Inc. • Adamas Pharmaceuticals, Inc. • Novartis AG,H. Lundbeck A/S • Cerevel Therapeutics • Biogen • Daiichi Sankyo Company, Limited • F. Hoffmann La Roche Ltd. • TauRx Pharmaceuticals Ltd. • Johnson & Johnson Services, Inc. • AC Immune • Teva Pharmaceutical Industries Ltd. • GlaxoSmithKline plc. (GSK). Global healthcare 3D printing industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. The healthcare 3D printing industry was valued at USD 9.4 billion in 2022 and is estimated to witness a CAGR of 17.0% over the forecast period. Healthcare Additive Manufacturing Market Growth & Trends The global healthcare additive manufacturing market size was estimated at USD 7.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 18.1% from 2023 to 2030. The growing demand for customized medical and dental additives, including personalized implants, medical models, orthodontic appliances, splints, dental models, and others, is expected to drive the market's growth over the forecast period. In healthcare, the requirement of every patient is unique, which has led to the high potential of additive manufacturing for customized and personalized medical applications. Moreover, the rising initiatives by the organization and the government to support small and medium-sized companies are expected to propel growth. For instance, in May 2022, U.S. President Joe Biden launched Additive Manufacturing Forward by joining five leading manufacturers in the U.S. to aid small-sized suppliers based in the U.S. to increase the utilization of additive manufacturing. 3D Bioprinting Market Growth & Trends The global 3D bioprinting market size was valued at USD 2.0 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12.48% from 2023 to 2030. The market is driven by the global organ donation shortage and utilization and demand for 3D Bioprinting to reduce animal testing of chemical, cosmetic, and pharmaceutical products. According to the organdonor.gov by the Health Resources and Services Administration, as of January 2023, around 104,234 individuals in the U.S. were waiting for organ transplantation list in the U.S. and around 88,901 individuals among them were waiting for kidney transplantation. Moreover, 3D Bioprinting is increasingly used as an alternative to animal experimentation in biomedical research. For instance, in February 2022, Bioprinting by light-sheet lithography: engineering of complex tissues with high resolution at a high-speed project (BRIGHTER Project) collaborated with the Institute of Bioengineering of Catalonia (IBEC) in the development of technology for the production of functional human tissues to replace animal testing. 3D Printed Drugs Market Growth & Trends The global 3D printed drugs market size was valued at USD 86.2 million in 2022 and is expected to expand at a CAGR of 14.78% from 2023 to 2030. The rising demand for personalized medicine and the growing adoption of R&D activities for the adoption of 3D printing in drug manufacturing is expected to drive the market growth during the forecast period. 3D printed drugs can manufacture tailored dosages and significantly reduce the cost of the products; hence, many pharmaceutical corporations are adopting this technology to innovate the products. For instance, in February 2020, Merck collaborated with AMCM to develop and produce GMP tablet formulation by 3D printing technology for clinical trials and commercial manufacturing services. Order your copy of Free Sample of “Healthcare 3D Printing Industry Data Book - Healthcare Additive Manufacturing, 3D Bioprinting and 3D Printed Drugs Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Competitive Landscape Key players operating in the Healthcare 3D Printing Industry are – • 3D Systems, Inc. • EnvisionTEC • Stratasys Ltd. • Allevi, Inc. • GE Healthcare • Nanoscribe GmbH • Materialise N.V. • Cyfuse Biomedical • RegenHU • Renishaw Global Biobanking Industry databook is a collection of market sizing & forecasts insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.The following data points will be included in the final product offering in four reports and one sector report overview. Biobanks Market Growth & Trends Biobanks market was valued at USD 66.06 Billion in 2021 with CAGR of 4.6% during 2022-2030. Biobanks market has been into existence since more than 60 years and it continues to evolve with introduction of new technologies such as NGS and increased focus on regenerative medicine. The collective popularity of precision/personalized medicine and genetic testing has been a key driver of the global biobanks market. Biobanks have been playing a significant role in biomedical research. Over the past few decades, there have been a number of advances in platforms and tools used in genetic studies. This has led to an increase in demand for biospecimens from clinical labs to develop assays and tissue models for genetic testing. Biobanking of samples provides an opportunity to understand the genetic foundation of diseases. Biobanks aid in drug discovery, in development of personalized medicine and therapies as they provide sample collection, storage, and distribution services. The Biobank data can be used to translate the genetic discoveries into practical personalized treatments. Cell Banking Outsourcing Market Growth & Trends Cell banking outsourcing market was valued at USD 9.86 billion in 2021 with CAGR of 16.39% during 2022-2030. In cell banking outsourcing market, master cell banking accounted for the largest share of 64.7% in 2021 owing to their preparation being a prerequisite for production and usage of working cell banks. Master cell banking is done for longer duration and it also requires high-end equipment and advanced cryopreservation methodologies. As a result, cost incurred for these services is quite high, thus increasing the revenue share of this segment. Some of the major factors driving the market growth include increasing adoption of stem cell therapy, development of advanced cryopreservation and cell banking methodologies, and high demand for mAbs and other life-saving biopharmaceuticals. Furthermore, increasing government support and new initiatives for the development of stable cell lines along with development of new technologies for better cell line storage and characterization are some key factors pushing the market growth during the assessment period. Order your copy of Free Sample of “Biobanking Industry Data Book - Biobanks, Cell Banking Outsourcing, Cord Blood Banking Services, DNA & RNA Banking Services Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Cord Blood Banking Services Market Growth & Trends Cord blood banking services market was valued at USD 35 billion in 2021 with CAGR of 11.0% during 2022-2030. In cord blood banking services market, private banking services segment held the largest market share with more that 90% of the market. This segment is expected to maintain its dominance because of the entry of new market players in the developing region. The public banking segment is expected to grow at a relatively slow rate. These type of banks are mostly found in developed regions. However, the hybrid banks segment is expected to exhibit fastest growth over the forecast period. Private banks comprise industry participants that offer cord blood banking services for a particular individual and their family members. This service is provided at a substantial fee that is either charged in one go or may be divided into annual fee over the total duration of storage. Services offered by private cord blood banks include long-term storage of cord blood components that are to be used by donors or relatives when needed, which involves high service cost. Currently, major private banks are expanding their businesses by implementing strategies such as geographical expansion, affordable pay packages, and expanding their services offerings. Competitive Landscape Key players operating in the Biobanking Industry are – • DANAHER CORPORATIONDANAHER CORPORATION • Tecan Trading AG. • THERMO FISHER SCIENTIFIC, INC. • QIAGEN • MERCK KGAA • HAMILTON COMPANY • BECTON, DICKINSON AND COMPANY • AVANTOR • PROMOCELL GMBH • BIOCISION • CHARLES RIVER LABORATORIES • BIOVAULT FAMILY • LONZA GROUP AG • BIO RELIANCE • STEMCELL TECHNOLOGIES INC. • BIO OUTSOURCE (SARTORIOUS) • BSL BIOSERVICE • CRYO-CELL INTERNATIONAL, INC • COVANCE • GLOBAL STEM INC. • GOODWIN BIOTECHNOLOGY INC. • SGS LIFE SCIENCES • CHINA CORD BLOOD CORPORATION • CORD BLOOD AMERICA, INC. • CBR SYSTEMS, INC. • CRYO-SAVE AG • LIFEFORCE CRYOBANKS • NATIONAL CORD BLOOD PROGRAM • VIACORD, INC. • VIRGIN HEALTH BANK • EASYDNA Female Infertility Industry Helps In Cracking The Fertile Code: Innovation And Advancements1/19/2024 Global female infertility industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a digital healthcare statistics e-book.
The global female infertility market size was valued at USD 25.7 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.97% from 2023 to 2030. In Vitro Fertilization Market Growth & Trends The global In-Vitro Fertilization (IVF) market size was valued at USD 23.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.72% from 2023 to 2030. This can be attributed to higher success rates and the introduction of advanced technologies, such as Percutaneous Epidydimal Sperm Aspiration and Testicular Sperm Extraction (PESA & TESE), three-parent IVF, mini-IVF, and others. Moreover, an increase in government funding for IVF is expected to boost segment growth over the forecast period. For instance, in May 2022, in Australia, under NSW Government 2022-23 budget, women in New South Wales opting for IVF will be provided with a USD 2,000 cash rebate to reduce the costs of the treatment for patients. Fertility clinics and hospitals are key end-use segments analyzed in this study. Fertility clinics accounted for the maximum share of the market in 2022 and will continue to dominate the market during the forecast period, being the most preferred setting for physicians and surgeons. Licensed fertility clinics offer counseling to couples facing problems in conceiving. Based on the severity of their problems, doctors and specialists plan their IVF treatment. The IVF treatments offered by hospitals are generally more expensive than fertility clinics. IVF treatments require highly skilled physicians and staff. Hence, employing dedicated staff for IVF in hospitals is a less preferable approach. Artificial Insemination Market Growth & Trends The global artificial insemination market is valued at USD 2.1 billion as of 2022 and is expected to expand at a CAGR of 8.58% for the forecast period 2023-2030. This can be majorly attributed to the demand for minor fertility treatments and lower costs of treatment compared to IVF. Intrauterine insemination is the preferable treatment among all types of artificial insemination procedures. The intrauterine mode of insemination involves placing the sperm sample directly in the uterus and yields higher pregnancy rates. It is a non-invasive technique and is preferred by most of the infertile couples. The market’s growth is driven by the lower cost of treatment, which is more suitable for minor fertility conditions and same-sex couples or single women. As per Human Fertilization and Embryology Authority (HFEA), the success rate of artificial insemination per cycle ranges from 15.8% for women under 35 to 11% for women aged 35 to 39, and 4.7% for women aged 40 to 42. Over the first six cycles, more than half of the women who had IUI reported pregnancy. IUI is preferred over other methods as it is noninvasive, affordable, can be easily performed, there are minimum risks involved, and is easy to train. The pregnancy rate by IUI is higher than that by other modes of insemination. Order your copy of Free Sample of “Female Infertility Industry Data Book - In Vitro Fertilization (IVF) and Artificial Insemination Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Competitive Landscape Key players operating in the Female Infertility Industry are – • Ferring B.V. • Vitrolife AB • CooperSurgical, Inc. • Cosmos Biomedical Ltd. • Merck KGaA • Cryolab Ltd. • FUJIFILM Irvine Scientific • Bloom IVF Centre • Microm UK Ltd. • OvaScience • Irvine Scientific • Progyny, Inc. • EMD Serono Inc. • Thermo Fisher Scientific Inc. • Boston IVF Global cancer diagnostics industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.
The global cancer diagnostics market is combined to account for USD 45.66 billion revenue in 2022, which is expected to reach USD 89.02 billion by 2030, growing at a cumulative rate of 5.97% over the forecast period. Breast Cancer Diagnostics Market Growth & Trends The global breast cancer diagnostics market size was valued at USD 16.26 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.24% from 2023 to 2030. The growth can be attributed to the increasing prevalence of cancer and rising government initiatives to increase the screening and diagnostic rate. Increased R&D in advanced breast cancer screening tools is anticipated to boost the market significantly. The UK Research and Innovation, in February 2020, received over USD 1300 million from the Engineering and Physical Sciences Research Council to develop a novel Raman spectroscopy platform for noninvasive and in vivo diagnostics of breast cancer. The approach would allow immediate and accurate diagnosis in conjunction with mammography by improving surveillance or screening techniques that would lead to better treatment outcomes & early diagnosis. Moreover, increased product launch is anticipated to boost market growth over the forecast period. In February 2023, NGeneBio launched an NGS-based breast cancer diagnostics test in Thailand. Moreover, in October 2022, NAMIDA LAB announced plans to launch Auria, an at-home breast assessment test. Thus, an increase in such initiatives undertaken by market players is expected to propel the adoption of breast cancer diagnostic tests in the near future. Cervical Cancer Diagnostic Market Growth & Trends The global cervical cancer diagnostic market was valued at USD 4.55 billion in 2022 and is projected to grow at a CAGR of 5.65% over the forecast period. Women between the age group of 20 and 60 years are usually more prone to this ailment, which is expected to increase cervical cancer screening and diagnostics procedures. New approvals and product launches due to high investments by market players are likely to boost the market. In November 2021, Hologic, Inc. announced the Genius Digital Diagnostics System launch and made it commercially available in Europe. This innovative NGS system combines advanced volumetric imaging technology with AI. In March 2023, Roche entered into a partnership with CAPED for the launch of a cervical cancer screening program in India to enhance and promote cancer care globally. The increase in the use of novel products by major market players for various cervical screening programs is expected to boost the market during the forecast period. Lung Cancer Diagnostics Market Growth & Trends The global lung cancer diagnostics market size was estimated at USD 10.82 billion in 2022. Technological advancements in tumor diagnosis contribute to market growth. An increase in the availability of various technologically advanced products for cancer diagnostics is a major factor anticipated to fuel the market during the forecast period. Companies such as Oncocyte offer DetermaDx, a multigene assay that can help measure gene expression in circulating blood cells to identify lung nodules, avoiding invasive biopsy procedures. In January 2020, Oncocyte acquired Insight Genetics to develop a PCR-based Immune Modulation (IM) Score Test. The test is expected to help measure the state of the immune system during a biopsy procedure and identify patient response to PD-1/PD-L1 immunotherapies. Similarly, in March 2023, Roche Diagnostics Korea announced the launch of uPath PD-L1, an automated AI tool used to detect PD-L1 biomarkers in NSCLC patients. Moreover, in June 2022, Biocartis received a CE marking for Idylla GeneFusion Panel, which is an IVD-based lung cancer screening solution for laboratories. Such innovative product launches are anticipated to drive the market growth over the forecast period. Order your copy of Free Sample of “Cancer Diagnostics Industry Data Book - Breast Cancer Diagnostic, Cervical Cancer Diagnostic, Lung Cancer Diagnostic, Liver Cancer Diagnostic, Pancreatic Cancer Diagnostic and Ovarian Cancer Diagnostic Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Pancreatic Cancer Diagnostic Market Growth & Trends The global pancreatic cancer diagnostic market size was valued at USD 3.63 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.43% from 2023 to 2030. Several key factors are driving the global market for pancreatic cancer diagnostics. Factors include the increasing prevalence of pancreatic cancer and a growing awareness of the importance of early disease diagnosis. Additionally, advancements in technology have led to improved accuracy and sensitivity of diagnostic tests and the evolution of molecular diagnostics and biomarker tests for detecting malignancies. These factors collectively propel the market demand for pancreatic cancer diagnostic solutions. Early diagnosis plays a crucial role in achieving positive treatment outcomes for pancreatic cancer. Consequently, market players and healthcare organizations are actively raising funds, conducting awareness programs, and initiating research initiatives to promote routine checkups and screenings. For example, in August 2022, the Pancreatic Cancer Action Network (PanCAN) awarded USD 10.5 million in grants to support 16 new research and development projects focused on early detection and improved treatment options for pancreatic cancer. Ovarian Cancer Diagnostics Market Growth & Trends The global ovarian cancer diagnostics market size was estimated at USD 4.41 billion in 2022 and is expected to grow at a CAGR of 4.93% during the forecast period. An increase in the number of R&D activities to develop novel diagnostic tests for ovarian cancer is expected to propel the market. For instance, scientists from the University of Gothenburg and Uppsala University developed a blood test that can provide precise diagnostics for ovarian cancer, which could eliminate the requirement for exploratory surgery. This novel test can decrease the requirement for surgery and aid in the early detection and treatment of affected women. In February 2020, a study conducted by two hospitals in Australia focused on women with advanced ovarian cancer. It used an immune marker for inflammation and other cancer markers to detect epithelial ovarian cancer. The test can be used by women staying in remote areas or disadvantaged communities, where there are limited resources for diagnosis of ovarian cancer, thus improving their chances of survival. The blood test is used to measure a body’s immune response to enhance the diagnosis of ovarian cancer. Liver Cancer Diagnostics Market Growth & Trends The global liver cancer diagnostics market size was valued at USD 5.99 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 5.96% by 2030. Liver cancer is a significant contributor to cancer-related deaths worldwide. According to the American Cancer Society, the incidence of liver cancer has tripled in the last three decades, with death rates also doubling. In 2022, it was approximately 41,260 new cases of liver cancer will be diagnosed in the U.S., resulting in approximately 30,520 deaths. The global prevalence of liver cancer, combined with the continuous exposure of the population to risk factors, will drive the rapid growth of the screening and diagnosis market. Various risk factors contribute to the development of liver cancer, including lifestyle choices such as smoking, alcohol consumption, and tobacco chewing, as well as underlying conditions like chronic viral hepatitis (hepatitis B virus or hepatitis C virus), cirrhosis, type 2 diabetes, and obesity. The presence of one or more risk factors increases the likelihood of liver cancer. Accurate early detection, diagnosis, and staging are crucial for improving survival rates. Key players operating in the Cancer Diagnostics Industry are – • GE Healthcare • Abbott • F. Hoffmann-La Roche Ltd., • QIAGEN • BD • Siemens Healthcare GmbH, • Thermo Fisher Scientific; Inc. • Hologic, Inc. • Koninklijke Philips N.V. (Philips) • IIumina, inc. Livestock Artificial Insemination Industry | Breeding Brilliance and Cutting Edge of Livestock AI1/16/2024 Global livestock artificial insemination industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.
The global livestock artificial insemination market size was estimated at USD 6.45 billion in 2022 and is anticipated to increase at a CAGR of 6.30% from 2023 to 2030. Bovine Artificial Insemination Market Growth & Trends The global bovine artificial insemination market size was valued USD 2.84 billion in 2022, registering a CAGR of 6.17% over the forecast period, according to a new report by Grand View Research, Inc. Some of the key factors driving the growth include the increasing uptake of artificial insemination solutions, technological advancements, demand for meat, milk, and dairy products, and supportive initiatives by the private & public sectors. In 2022, for instance, ABS Global - the bovine genetics division of Genus plc, reported a revenue of USD 340.64 million with an estimated 3% increase in volumes of bovine semen and embryo. The company also reported an 18% increase in volumes of sexed semen for its Sexcel and IntelliGen portfolios. Equine Artificial Insemination Market Growth & Trends The global equine artificial insemination market size was valued USD 0.64 billion in 2022, expanding at a CAGR of 5.80% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising adoption of artificial insemination (AI) in horses, awareness about the benefits of AI, and demand to increase animal productivity are some of the key factors propelling the market growth. For instance, AI eliminates the risks associated with handling aggressive stallions, reducing the chances of injuries to both horses and handlers. It also enables breeders to manage and monitor mare fertility more effectively. By controlling the timing of insemination and monitoring the mare's reproductive cycle, breeders can optimize the chances of successful conception. Furthermore, AI facilitates breeders to access stallions located in different parts of the world without the need for transporting the animals physically. This opens up opportunities for international and long-distance breeding, facilitating the exchange of genetic material across borders. These factors are expected to fuel the market growth in the coming years. Swine Artificial Insemination Market Growth & Trends The global swine artificial insemination market size was valued USD 1.91 billion in 2022, expanding at a CAGR of 6.67% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is characterized by initiatives by key companies, demand for sustainable food production, consumption of pork, and growing uptake of artificial insemination in swine. Semen Cardona S.L. one of the key players in the market reported that the company was exploring opportunities in emerging markets such as Mexico, Colombia, and the Philippines. In the year 2022 alone, the company distributed more than 0.7 million semen doses in Mexico with scope for further growth. Similar initiatives are propelling market growth. Moreover, the increasing consumption of pork is anticipated to contribute to the demand for AI services to ensure production safety, sustainability, and efficiency. Consumption of pork meat is expected to increase from 112.58 megatons to 127.27 megatons from 2022 to 2029 according to estimates by OECD. Order your copy of Free Sample of “Livestock Artificial Insemination Industry Data Book - Bovine, Equine, Swine, Ovine & Caprine Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Ovine And Caprine Artificial Insemination Market Growth & Trends The global ovine and caprine artificial insemination market size was valued USD 1.06 billion in 2022, expanding at 6.25% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Drivers contributing to the market growth include increasing access to buck (a male goat) and ram (a male sheep) semen, improved reproductive efficiency by adopting artificial insemination, and demand for genetic improvement in the sheep and goat industries. Artificial insemination allows farmers and breeders to access high-quality genetics from superior male animals. By using AI, they can introduce desired traits such as improved meat quality, milk production, disease resistance, and reproductive performance into their herds or flocks. As technology continues to advance and demand for quality genetics grows, the market is expected to expand further during the forecast period. Key players operating in the Livestock Artificial Insemination Industry are – • Genus Plc • SEMEX • URUS Group • STgenetics • Munster Bovine • Stallion AI Services • MINITÜB GMBH • IMV Technologies • B&D Genetics • SEK Genetics • Semen Cardona S.L. • Swine Genetics International Global diagnostic imaging industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.
The global diagnotic imaging market size was valued at USD 29.47 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 4.83% from 2023 to 2030. Computed Tomography Market Growth & Trends The global computed tomography market size was valued at USD 4.2 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7.43% from 2023 to 2030. Technological advancements in CT technology, coupled with the growing prevalence of chronic disorders such as cancer, orthopedics, and cardiovascular and neurological conditions are expected to accelerate the market growth. CT scan is a most important diagnostic tool, predominantly for traumatic brain injuries and lung cancer. The prevalence of these illnesses is fostering market expansion. The growing elderly population, the prevalence of chronic diseases, the change in medical care toward image-guided interventions, and technology improvements are further market drivers. Lung cancer is one of the most frequently diagnosed cancer, according to the American Cancer Society, Inc., around 238,340 residents in the U.S. are expected to get diagnosed with lung cancer, and 127,070 deaths are estimated in 2023. Additionally, the organization has stated that 654,620 inhabitants have a history of lung cancer, among which about 80% of patients were of age 65 years or above as of January 2022. Incidences of lung cancer are predicted to rise by 38% to 2.89 million globally by 2030. A CT scan produces 3D images of the bones that aid in orthopedic surgery and improved diagnosis. Consequently, as the prevalence of orthopedic problems rises, so does the need for CT increases, leading to the market growth. Magnetic Resonance Imaging Market Growth & Trends The global magnetic resonance imaging market size was valued at USD 5.25 billion in 2022 and is expected to expand at a CAGR of 6.81% from 2023 to 2030. Magnetic Resonance Imaging (MRI) is an efficient diagnostic machine for identifying diseases related to spine lesions, tumors, and strokes impacting the area of blood vessels and the brain. The increasing prevalence of diseases is driving the market growth. Moreover, Magnetic resonance imaging is a crucial technique to diagnose cancer/tumor and to plan treatment such as radiation therapy or surgery for cancer patients. Hence, the increasing burden of cancer is expected to fuel the MRI market globally. For instance; according to National Center for Health Statistics, in 2023, almost 1,958,310 new cancer cases and 609,820 cancer deaths are estimated to occur in the United States. Nuclear Imaging Market Analysis And Forecast The global nuclear imaging market size was estimated at USD 4.67 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.95% from 2023 to 2030. Factors such as changing preference from standalone devices to hybrid imaging modalities, growing focus on personalized medicinal treatments, advancements in the healthcare infrastructure, and rising prevalence of chronic diseases such as cardiac ailments & cancer are fueling the nuclear imaging market’s growth during the forecast period. Rising awareness levels among physicians and clinical researchers regarding the benefits of nuclear imaging coupled with increasing application areas such as cases in oncology, and neurological diseases are the factors driving PET and SPECT market. Furthermore, the increasing geriatric population and expanding horizon of applications in SPECT and PET imaging owing to constant discovery and developments of new radiopharmaceuticals are driving the diagnostic imaging market. Order your copy of Free Sample of “Diagnostic Imaging Industry Data Book - Computed Tomography, Magnetic Resonance Imaging, Nuclear Imaging, Ultrasound Device and X-ray Systems Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Ultrasound Device Market Analysis And Forecast The global ultrasound device market size was valued at USD 7.36 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.03% from 2023 to 2030. The rising use of ultrasound equipment for diagnostic imaging and therapy, as well as the rising prevalence of chronic and lifestyle-related illnesses are the key factors anticipated to drive the market’s growth. Additionally, technological advancements in ultrasound devices, and rising demand for minimally invasive surgeries are expected to create lucrative growth opportunities. Ultrasound technology is used in various application areas such as cardiology, obstetrics/ gynecology, vascular, orthopedic, and general imaging. The rising prevalence of cardiac disorders is expected to boost the ultrasound device market globally. According to WHO, Cardiovascular diseases (CVDs) are the major cause of death globally, taking approximately 17.9 million lives each year. Additionally, as per the Centers for Disease Control & Prevention, in the United States, every year about 805,000 people have a heart attack and about 1 in 20 adults age 20 and older have Coronary Artery Disease (about 5%). X-ray Systems Market Analysis And Forecast The global x-ray systems market size was valued at USD 7.89 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 2.28% from 2023 to 2030. Rising demand for early disease diagnosis, constant technological advances, increase in product development, favorable healthcare funding, and rising government investments in developing countries are expected to fuel the market growth. Additionally, the rising geriatric population and growing prevalence of orthopedic trauma due to severe accidents are some of the inevitable factors supporting the market’s growth. According to United Nations, the number of people aged 65 years or above is expected to reach 1.6 billion in 2050, accounting for more than 16% of the global population. The geriatric population is prone to develop conditions such as arthritis, osteoporosis, and bone fractures. According to the Centers for Disease Control and Prevention, around 23.7% or nearly 58.5 million inhabitants are diagnosed with arthritis. More women (23.5%) are predominantly suffering from the disease compared to men (18.1%). The facial rejuvenation products industry database, compiled by Grand View Research, is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.
The global facial rejuvenation products market size was valued at USD 109.03 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2030. Facial Injectable Market Growth & Trends The global facial injectable market size was estimated at USD 12.7 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.3% from 2023 to 2030. A growing focus on physical appearance among consumers has led to an increased demand for facial injectables in recent years. Increasing awareness regarding minimally invasive procedures due to various beauty campaigns being organized by key players in the market is also a driving factor for market growth. The ongoing COVID-19 pandemic has increased the time spent on video calls. Known as the ‘Zoom Boom’, several adults are becoming more aware of their appearance. This has increased demand for cosmetic surgeries, with Botox being one of the most popular products preferred. Skin Boosters Market Growth & Trends The global skin boosters market size was estimated at USD 1.03 billion in 2022 and is expected to grow at a CAGR of 9.6% from 2023 to 2030. The desire to look youthful among the millennials and the rising consumption of aesthetic procedures by both men and women, especially from emerging economies are majorly estimated to drive the market. However, the advent of the COVID-19 pandemic has hugely affected the overall non-invasive aesthetic industry. However, many aesthetic professionals believe that pandemics might most likely propel the overall growth of the aesthetic market. Many dermatology clinics have witnessed a boost in the number of future appointments and consultations for different skin treatments and this is expected to boost the market growth. Facial Skincare Market Analysis And Forecast The global facial skincare market size was estimated at USD 90.8 billion in 2022 and is expected to grow at a CAGR of 5.8% from 2023 to 2030. Rising awareness regarding the importance of facial products in maintaining healthy skin, enhancing skin appearance, and minimizing skin conditions is driving the industry of these products. In the past few years, facial care products have contributed to almost 70.0% share of the overall revenue in the skincare market. Manufacturers have realized the significance of these products among consumers and have shifted their focus toward facial beauty products. Manufacturers have started their brand campaigns through various social media platforms such as Facebook, Instagram, and YouTube to market their products. Key players have collaborated with different celebrities and appointed them as brand ambassadors of their products to attract more customers. Order your copy of Free Sample of “Facial Rejuvenation Products Industry Data Book - Facial Injectable, Skin Boosters, Facial Skincare and Anti-Acne Cosmetics Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Anti-acne Cosmetics Market Growth & Trends The global anti-acne cosmetics market size was estimated at USD 4.5 billion in 2022 and is expected to grow at a CAGR of 9.1% from 2023 to 2030. The negative social stigma associated with acne and the rising consumption of cosmetics by both men and women, especially from emerging economies are majorly estimated to drive the market growth. The incidence of acne increased during the pandemic, which, in turn, accelerated the market growth. Acne is a highly prevalent skin disorder among adolescents. According to an article published by the Journal of The European Academy of Dermatology and Venereology, more than 95% of boys and nearly 85% of girls are affected by acne during their adolescence. Out of these, nearly 40% experience moderate‐to‐severe acne and nearly 50% continue to have acne in their adulthood. The high prevalence of acne, especially in the young population, is anticipated to fuel market growth. Competitive Landscape Key players operating in the Facial Rejuvenation Products Industry are – • Ipsen • Merz Pharma • Suneva Medical, Inc. • Medytox Inc. • Sinclair Pharma • Bloomage BioTechnology Corporation Limited • Anika Therapeutics Inc. • Prollenium Medical Technologies • Galderma • Allergan, Inc. • Nestle Skin Health • Zimmer Biomet • Abbvie Inc • SciVision Biotech Inc • Croma-Pharma GmbH • Revance Therapeutics Inc • Bioplus Co. Ltd • Bioaxis Pharmaceuticals Global clinical laboratory industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.The following data points will be included in the final product offering in two reports and one sector report overview.
The global clinical laboratory market combine to account for USD 321.20 billion in revenue in 2022, which is expected to reach USD 493.72 billion by 2030, growing at a cumulative rate of 5.52% over the forecast period. The combination bundle is designed to provide a holistic view of these highly dynamic market spaces. Clinical Laboratory Tests Market Growth & Trends The global clinical laboratory tests market was valued at USD 103.67 billion in 2022 and is anticipated to witness growth at a rate of 9.42% over the forecast period. The market growth can be attributed to the increasing adoption of clinical laboratory tests, increasing prevalence of targeted diseases, and rising geriatric population. According to the UN data, in 2020, there were around 727 million individuals aged 65 and above globally. Moreover, the share of the global population aged 65 and above is expected to grow from 10% in 2022 to 16% in 2050. Aging is considered a great risk factor for developing chronic diseases, which is expected to fuel the demand for clinical laboratory tests over the forecast period. Growing prevalence of target diseases such as cardiovascular diseases, diabetes, and others is anticipated to fuel market growth. According to the WHO, in 2021, cardiovascular diseases are the leading cause of death globally. Around 17.9 million people die each year due to CVDs, which is about 31% of total death worldwide. The mortality rate of CVDs is higher in low and middle-income countries compared to high-income countries due to the low penetration rate of clinical tests in these regions. High unmet medical needs in developing regions are anticipated to create new opportunities for the market stakeholders. Moreover, increasing awareness among people regarding early diagnosis of diseases is anticipated to propel the market growth over the projected period. Clinical Laboratory Service Market Growth & Trends The global clinical laboratory service market was valued at USD 217.53 billion in 2022 and is anticipated to witness growth at a rate of 3.24% over the forecast period. Increasing burden of chronic diseases, growing demand for early diagnostic tests, and increasing research activities to develop novel diagnostic and therapeutic solutions are expected to increase the market for clinical laboratory service market. Moreover, advancements in data management and sample preparation due to the growing volume of testing are further supporting the market growth. Increasing research activities by pharmaceutical & biotechnology companies and research & academic institutes are driving the demand for clinical laboratory services to study different health conditions across the globe. As of January 2023, ClinicalTrials.gov registered 439,527 research studies, out of which, around 31% of clinical studies were registered in the U.S. Moreover, the presence of intense research activities related to genetic & proteomics, cancer, and other life-threaten diseases is expected to drive revenue generation in the coming years. Presence of several genetic and tumor tests in the development phases is further anticipated to fuel the market growth. Most research studies are being conducted in North America and Europe region. A large number of clinical studies conducted in these regions are due to favorable government policies, the presence of strong market players coupled with heavy investments done by them in R&D activities. However, research activities are expected to increase in the Asia Pacific region over in next couple of years. Increasing shift towards the APAC region, high unmet medical needs, low operational cost, and increasing contract research organizations in the region will boost the demand for clinical laboratory services in the region. Order your copy of Free Sample of “Clinical Laboratory Industry Data Book - Clinical Laboratory Tests and Clinical Laboratory Service Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Competitive Landscape Key players operating in the Clinical Laboratory Industry are – • Abbott • ARUP Laboratories • OPKO Health, Inc. • Bioscientia Healthcare GmbH • Charles River Laboratories • NeoGenomics Laboratories • Healthscope • Labco • Laboratory Corporation of America Holdings • Fresenius Medical Care AG & Co. KGaA • QIAGEN • Quest Diagnostics Incorporated • Siemens Healthcare GmbH • Tulip Diagnostics (P) Ltd • Sonic Healthcare Limited • Merck KGaA • Biosino Bio-Technology and Science Inc. • Cinven • DaVita Inc. • SGS Société Générale de Surveillance SA • Almac Group |
Archives
December 2023
Categories |